Emerging Trends in Nanomedicine

1. Auflage 2021
ISBN: 978-981-1599-19-4
Verlag: Springer Nature Singapore

Buch, Englisch, 240 Seiten, HC runder Rücken kaschiert, Format (B × H): 160 mm x 241 mm, Gewicht: 599 g

This book illustrates the significance of nanotechnology in the delivery of anticancer and antimicrobial drugs, biomimetic technologies, tissue engineering, sensing, diagnostics, and artificial enzymes. It first briefly discusses the use of nanotechnology for the delivery of anticancer medications, and the concept and applications of catalytically active nanomaterial-based artificial enzymes for sensing and diagnostic applications. It then explores the use of silver nanoparticle-based novel antimicrobials, and comprehensively reviews the role of nanomaterials in developing biomedical implants and tissue engineering applications. Lastly, it offers a detailed description of nanotherapeutics for combating human protozoan parasitic infections. Cutting across the disciplines, this book serves as a guide for researchers and scientists in biotechnology, medical science and material science.

Zielgruppe

Research

Autoren/Hrsg.

Singh, Sanjay

Fachgebiete

• Medizin | Veterinärmedizin Medizin | Public Health | Pharmazie | Zahnmedizin Klinische und Innere Medizin Onkologie, Krebsforschung
• Technische Wissenschaften Technik Allgemein Nanotechnologie
• Medizin | Veterinärmedizin Medizin | Public Health | Pharmazie | Zahnmedizin Vorklinische Medizin: Grundlagenfächer Molekulare Medizin, Zellbiologie
• Naturwissenschaften Biowissenschaften Zellbiologie

Inhaltsverzeichnis

Chapter 1. Strategies to improve oral delivery of natural anticancer molecules.- Chapter 2. Nanoparticles catalyzing enzymatic reactions: recent developments and future prospects.- Chapter 3. Biogenic silver nanoparticles: A potent therapeutic agent.- Chapter 4. Translational studies of nanofibers-based scaffold for skin and bone tissue regeneration.- Chapter 5. Functional Dendritic Coatings for Biomedical Implants.- Chapter 6. Application of nanotherapeutics for combating human protozoan parasitic infections.

Über Autor(innen)

Dr. Sanjay Singh is currently an Associate Professor at the Division of Biological and Life Sciences, Ahmedabad University, Gujarat, India. After completing his Ph.D. at CSIR-National Chemical Laboratory, Pune, India, he continued his research as a postdoctoral fellow at the University of Central Florida and the Pennsylvania State University, USA. His research interests include the synthesis of novel anti-cancer drug formulations and nanomaterials with biological, enzyme-like characteristics. He has received numerous national and international awards, such as an Endeavour Research Fellowship, YY Memorial Award (2016), International Association of Advanced Materials Scientists Medal (2017), Ambassador Australian Awards (2017), and an EMBO Fellowship.

Dr Singh has published over 80 papers in international, peer-reviewed journals, and authored and co-authored several books and book chapters. He has also worked as a guest editor for various annual meetings of the Society for Redox Biology and Medicine (SfRBM) and the World Molecular Imaging Society (WMIS). He is the Associate Editor-in-Chief of 3Biotech (Springer Nature), OncoTargets, and Therapy.